Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2011-07-01
2023-01-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For the general field of mental health one of the most important innovations involves providing therapists with patient feedback about their progress. The most well-established and widely researched feedback system is the Outcome Questionnaire (OQ-45.2). The system has been shown to improve treatment outcomes, including reduced treatment dropout and length of treatment, but the system is yet to be utilized with a substance abusing patient group. The aim of the present study is to examine the usefulness of OQ-45.2 with substance abusing patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing the Efficacy of an Online Alcohol Intervention
NCT01754090
Testing the Efficacy of an Online Alcohol Intervention in a Workplace Setting
NCT01931618
Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD
NCT06190236
Therapist-guided Internet Treatment for Hazardous and Harmful Alcohol Use. A Feasibility Study
NCT04544930
Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs)
NCT04822987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1\. The OQ-45.2 feedback will be effective in identifying patients at risk of dropout of substance abuse treatment.
1a. The condition were feedback is withheld from the therapist, will correctly identify patients who will dropout.
Research Question: Is there variation in the accuracy of dropout prediction as a function of age, gender differences or type of substance abuse?
2\. The OQ-45.2 feedback will be effective in reducing dropout in outpatient substance abuse treatment.
2a. The feedback condition will result in less dropout than the no-feedback condition.
Research Question: Is there a variation in the OQ-45.2 preventive dropout effect due to age, gender or type of substance abuse?
3\. The OQ-45.2 feedback will shorten length of inpatient substance abuse treatment.
3a. The feedback condition will identify patients who are ready to terminate therapy.
Research Question: Is there variation in identification of patients ready to terminate as a function of age, gender differences or type of substance abuse?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients merely monitored on background variables to function as a baseline of comparison
No interventions assigned to this group
Prediction
Patients randomized to this condition completes the OQ-45.2 weekly, but the reports are withheld from therapists and patients.
OQ-45.2 no feedback
Completion of the OQ-45.2 before each session, but no feedback to therapists or patients
Intervention
Patients and therapists uses the feedback-system as intended, with real-time feedback to the therapist and full use of the suggested interventions
OQ-45.2
Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OQ-45.2 no feedback
Completion of the OQ-45.2 before each session, but no feedback to therapists or patients
OQ-45.2
Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
26 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Espen Walderhaug
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of addiction treatment- youth
Oslo, , Norway
Oslo University Hospital - Department of addiction treatment youth
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context. Psychother Res. 2014;24(4):504-13. doi: 10.1080/10503307.2013.849016. Epub 2013 Nov 5.
Brorson HH, Arnevik EA, Rand K. Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst. Subst Abuse. 2019 Aug 15;13:1178221819866181. doi: 10.1177/1178221819866181. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OQ45-11-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.